Inventor
YU YOUNONG
US39 patents
⚠️ This page may combine multiple inventors who share the name “YU YOUNONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
15 patentsUS10472347B2Nov 12, 2019
Aminopyrazine compounds with A2A antagonist properties
MERCK SHARP & DOHME5 citations72
US10246457B2Apr 2, 2019
Indazole and azaindazole Btk inhibitors
MERCK SHARP & DOHME2 citations72
US10822338B2Nov 3, 2020
Substituted aminoquinazoline compounds as A2A antagonist
MERCK SHARP & DOHME2 citations71
US10093683B2Oct 9, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME4 citations71
US10011615B2Jul 3, 2018
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
MERCK SHARP & DOHME3 citations71
US9718828B2Aug 1, 2017
BTK Inhibitors
MERCK SHARP & DOHME7 citations71
US9676780B2Jun 13, 2017
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
MERCK SHARP & DOHME2 citations61
US9422277B2Aug 23, 2016
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use
MERCK SHARP & DOHME1 citations52
US9416129B2Aug 16, 2016
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use
MERCK SHARP & DOHME1 citations52
US9481682B2Nov 1, 2016
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
MERCK SHARP & DOHME2 citations51
US8569312B2Oct 29, 2013
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51
US8476274B2Jul 2, 2013
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51
US10130630B2Nov 20, 2018
BTK inhibitors
MERCK SHARP & DOHME0 citations40
US10392353B2Aug 27, 2019
Processes for making substituted quinazoline compounds using hydrogen bonding catalysts
MERCK SHARP & DOHME0 citations38
US9834554B2Dec 5, 2017
BTK inhibitors
MERCK SHARP & DOHME0 citations38
SCHERING CORP
12 patentsUS6878709B2Apr 12, 2005
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
SCHERING CORP20 citations92
US8003624B2Aug 23, 2011
Functionally selective ALPHA2C adrenoreceptor agonists
SCHERING CORP11 citations84
US7638531B2Dec 29, 2009
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
SCHERING CORP19 citations83
US7964646B2Jun 21, 2011
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
SCHERING CORP10 citations82
US7947720B2May 24, 2011
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
SCHERING CORP10 citations82
US7700592B2Apr 20, 2010
α2C adrenoreceptor agonists
SCHERING CORP8 citations82
US7338968B2Mar 4, 2008
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
SCHERING CORP4 citations62
US7691856B2Apr 6, 2010
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
SCHERING CORP3 citations61
US7671212B2Mar 2, 2010
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
SCHERING CORP4 citations61
US7960433B2Jun 14, 2011
Treatment of chemokine mediated diseases
SCHERING CORP4 citations58
US8017642B2Sep 13, 2011
Functionally selective ALPHA2C adrenoreceptor agonists
SCHERING CORP0 citations52
US7786149B2Aug 31, 2010
Thiadiazoles as CXC- and CC- chemokine receptor ligands
SCHERING CORP0 citations51
MERCK SHARP & DOHME LLC
3 patentsUS12590099B2Mar 31, 2026
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
MERCK SHARP & DOHME LLC0 citations52
US12281109B2Apr 22, 2025
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
MERCK SHARP & DOHME LLC0 citations51
US12246008B2Mar 11, 2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME LLC0 citations51